single
Ontario Expanding Access to COVID-19 Antivirals
As part of its plan to stay open and manage COVID-19 for the long-term, the Ontario government is expanding eligibility for COVID-19 antiviral treatments and PCR testing to more high-risk individuals. Doing so will offer increased protection to the most vulnerable and ensure hospital capacity remains stable.
Effective immediately, the following higher-risk groups are eligible to be tested and assessed for antiviral treatments, such as Paxlovid, in Ontario:
- Individuals aged 18 and over who are immunocompromised (have an immune system that is weakened by a health condition or medications);
- Individuals aged 70 and over;
- Individuals aged 60 and over with fewer than three vaccine doses; and
- Individuals aged 18 and over with fewer than three vaccine doses and at least one risk condition (e.g., a chronic medical condition)
Anyone who is eligible for an assessment is now also eligible for a PCR test at any testing centre in Ontario.
Beginning April 12, Ontario is making it easier for eligible individuals with a prescription to access antivirals by expanding dispensing locations to include participating pharmacies across the province. A list of pharmacies that are dispensing Paxlovid will be available at Ontario.ca/antivirals as of Wednesday, April 13 at 8:00 a.m.
For more information, read the full news report: Ontario Expanding Access to COVID-19 Antivirals | Ontario Newsroom